Sio Gene Therapies Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits